Epinephrine
- Product NDC
- 63083-1553
- 11-digit product format
- 630831553
- Labeler code
- 63083
- Product ID
- 63083-1553_45ccdc05-7de3-4a1b-a2c9-274a39b0db41
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Epinephrine
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Professional Complementary Health Formulas
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 1984-08-15
- Substance
- EPINEPHRINE
- Active strength
- 9 [hp_X]/29.5mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Epinephrine
- Brand name suffix
- 1553
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EPINEPHRINE | 9 [hp_X]/29.5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | YKH834O4BH |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63083-1553-1 | Epinephrine1553 | 29.5 mL in 1 BOTTLE, DROPPER | LIQUID | 29.5 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63083-1553 | EPINEPHRINE 1553 (EPINEPHRINE) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS] | 1 | Current NDC, Legacy NDC, 1 package rows | 20220301_c06d262b-b97e-4921-b927-c51e1b27691e.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63083-1553-1 | 63083155301 | 29.5 mL in 1 BOTTLE, DROPPER (63083-1553-1) | 29.5 ml | 1985-08-15 | 0000-00-00 | No | No | Current |